As Arrowhead Pharmaceuticals' stock skyrockets following its first FDA approval, one investment fund has taken profits, trimming a multimillion-dollar stake while maintaining a significant position in the high-flying biotech.
While Social Security benefits are shielded from most creditors, federal agencies and court orders can legally intercept portions of your monthly payment for unpaid debts. Here’s what retirees need to know.
A discounted cash flow analysis suggests Trustpilot Group's shares are trading close to their intrinsic value. We break down the model, its assumptions, and what it means for investors in the online reviews giant.
Eldorado Gold Corp. has agreed to acquire Foran Mining Corp. in a move that reshapes the mid-tier miner into a diversified gold-copper producer, capitalizing on soaring demand for metals critical to the global energy transition.
Shares in telecom tower operator IHS Holding surged following a strong operational update, highlighted by record free cash flow margins and a significant easing of foreign exchange headwinds from Nigeria. The company also outlined strategic moves in Brazil and potential asset sales, sharpening its focus on capital efficiency.
Etsy shares face sustained pressure despite solid revenue, as diverging growth expectations and a high P/E ratio spark debate over whether the stock is a hidden gem or a value trap. We analyze the key metrics and market sentiment.
Shares of data management firm Commvault Systems have tumbled over 30% in recent weeks, erasing year-to-date gains and prompting investors to question if the stock's premium valuation is still justified. We analyze key metrics and market sentiment to assess the road ahead.
As Netflix eyes a blockbuster acquisition of Warner Bros. Discovery, industry analysts warn that antitrust scrutiny, not competition from Paramount Skydance, presents the most formidable challenge to the deal's completion.
Bio-Techne's shares have rebounded to around $65, but a deep dive into valuation metrics reveals a complex picture. While a discounted cash flow model suggests the stock is near fair value, its sky-high P/E ratio tells a different story, raising questions about its long-term prospects.
Biotech firm Erasca, Inc. raised $225 million in a January 2026 follow-on equity offering, providing a substantial runway for its clinical-stage RAS-targeted cancer therapies. The capital infusion, alongside promising updates for programs like ERAS-0015 and ERAS-4001, has reignited debate on the company's valuation and path to commercialization.
Following a successful pilot in Saudi Arabia, the French luxury group and the Saudi Fashion Commission are widening their search for sustainable fashion innovators across the region, aiming to accelerate tangible solutions for the industry's environmental challenges.
Bank of America and Barclays have updated their price targets for Atmos Energy (ATO) following adjustments to long-term earnings estimates, highlighting the regulated utility's stable business model amidst a shifting economic landscape.
Shares of Soleno Therapeutics (SLNO) rallied nearly 9% after the company framed 2025 as a pivotal year, driven by the launch of its drug VYKAT XR. Despite the recent pop, the stock remains under significant pressure over the past quarter, highlighting the high-stakes bet investors are making on its commercial prospects.
The Dow Jones Industrial Average's three-week losing streak to close January has investors questioning its signal. While the blue-chip index's underperformance versus the S&P 500 highlights sector-specific pressures, analysts caution against overinterpreting its price-weighted quirks as a broader market harbinger.
The Flare blockchain, through a partnership with lending protocol Morpho, now enables XRP holders to lend their wrapped assets for yield or use them as collateral to borrow other cryptocurrencies, marking a significant expansion of DeFi utility for the token.
Despite trading significantly below its yearly peak, Netflix's stock is showing signs of a potential near-term recovery, according to options market data. Analysts point to a specific price target around $88 by mid-February, driven by a common trading theory, as a focal point for investors.
A controversial proposal to establish a ‘Ministry of Sex’ in Armenia, aimed at addressing women's dissatisfaction and low birth rates, has drawn fierce criticism as a sexist electoral ploy, highlighting deep political divisions ahead of June's parliamentary vote.
Prime Minister Donald Tusk announces a formal probe into potential links between the late Jeffrey Epstein and Russian intelligence services, warning of possible security implications for Poland and the broader West.
Syrian state security convoys have entered the key northeastern city of Qamishli, implementing a landmark U.S.-supported agreement to reintegrate Kurdish-administered regions. The move follows January's territorial gains by Damascus and aims to avert further conflict, though it was met with local protests.
In a move seen as a diplomatic gesture, Colombian President Gustavo Petro ordered the extradition of a major drug trafficker to the United States just hours before his first official meeting with President Donald Trump, following months of suspended extraditions and public tensions.
